Don Miller, Senior Content Manager at MarketBeat

Articles Reviewed by Don Miller - Page 52

January 10, 2024 5:05 AM ET

Will Danaher stock hit new highs in 2024?

Thomas Hughes

Danaher raises guidance, sending shares higher, but the move may not last. Resistance is just above current levels and may cap gains until later in the year.

NYSE:DHR

January 10, 2024 5:00 AM ET

3 health care stocks off to strong starts in 2024

MarketBeat Staff

With the bullish news flow lately, the market has taken a liking to health care stocks in recent weeks - including these three early 2024 gainers.

NASDAQ:AMGNNASDAQ:REGNNASDAQ:GILD

January 9, 2024 12:18 PM ET

Nike navigates a new course without Tiger

Jeffrey Neal Johnson

Nike's split with Tiger Woods after 27 years triggered a cautious market reaction and demanded a strategic shift in its golf apparel and endorsements.

NYSE:NKEOTCMKTS:ADDYYNYSE:UAA

January 9, 2024 6:49 AM ET

Apple just flashed the mother of all buy signals

Sam Quirke

It rarely happens, but when Apple’s Relative Strength Index (RSI) hits 30 or below, it’s almost always followed by a fresh rally.

NASDAQ:AAPL

January 9, 2024 6:45 AM ET

Acuity Brands stock: A good play on falling rates

Thomas Hughes

Acuity Brands had a decent quarter, with margin expanding significantly and raising the expectations for 2024. The stock is moving higher but faces resistance.

NYSE:AYI

January 9, 2024 6:10 AM ET

Five Below falls below EMA; is it time to buy the dip?

Thomas Hughes

Five Below reaffirmed its guidance, but the market wanted more. Now, the stock is down 5% and in a position where sell-siders may buy the dip.

NASDAQ:FIVE

January 9, 2024 6:10 AM ET

Where will S&P 500 go after new bullish levels?

Kate Stalter

Major indexes look resilient despite 2024's rocky start, getting support at key moving averages. Upcoming earnings could be catalysts in either direction.

NYSE:ALKNASDAQ:AALNYSE:LLY

January 9, 2024 6:10 AM ET

3 bullish mid-cap earnings plays for January 2024

MarketBeat Staff

With U.S. mid-caps trading at relatively low valuations, some of the biggest fourth quarter earnings pops could come from these three names.

NYSE:LRNNYSE:BMINYSE:CLS

January 9, 2024 6:05 AM ET

4 hot midcaps that the insiders are buying

Thomas Hughes

Here's a look at the four hot midcaps insiders bought most in Q4 2023. Some are good buys, some are wait-and-see, and some it's time to say goodbye.

NYSE:MODGNASDAQ:FFINNYSE:CW

January 9, 2024 5:18 AM ET

Mobileye gets poked on weak forecasts, buying opportunity

Jea Yu

Advanced driver assistance systems (ADAS) and autonomous driving technology provider Mobileye Global Inc. (NASDAQ: MBLY) shocked investors when it unexpectedly

NASDAQ:MBLYNYSE:GMNYSE:F

January 9, 2024 5:13 AM ET

Chevron stock made it to Barron's top 2024 picks

Gabriel Osorio-Mazilli

Chevron is quickly becoming the oil industry's favorite name, with major players backing the idea of a bull run coming soon to the name, it's a worthy addition

NYSEARCA:XLENYSE:GSNYSE:XOM

January 8, 2024 5:43 PM ET

Johnson & Johnson: Biotech a shot in the arm for future growth?

Jeffrey Neal Johnson

Johnson & Johnson is actively shifting its strategy towards biotechnology and antibody-drug conjugates, balancing current revenue protection with future growth.

NYSE:JNJNYSE:AMAM

January 8, 2024 11:13 AM ET

Boeing Takes a hit after 737 Max grounding

Jeffrey Neal Johnson

Boeing is navigating a critical situation with its 737 Max, addressing safety concerns and market repercussions to rebuild trust and ensure future stability.

NYSE:BANYSE:ALKNYSE:GS

January 8, 2024 10:45 AM ET

Boeing stock gaps down 8.50% on new round of 737 Max woes

Kate Stalter

Boeing stock dropped 8.50% after a door panel fell out of an Alaska Air 737 Max 9 aircraft. Boeing supplier Spirit AeroSystems also gapped down at the open.

NYSE:BANYSE:ALKNASDAQ:AAL

January 8, 2024 7:38 AM ET

Merck, the Dow's hottest stock, gets set to report Q4 financials

MarketBeat Staff

Up 5.7% year-to-date, pharmaceuticals - including MRK - are the best performing industry in the entire U.S. equity market, outpacing even biotech stocks.

NYSE:MRKNYSE:LLYNYSE:OGN

January 8, 2024 7:24 AM ET

Voyager Therapeutics stock pops 30% on deal with Novartis

Jea Yu

Voyager Therapeutics Inc. (NASDAQ: VYGR) is a biotech in the medical sector that specializes in gene therapy for neurological diseases. Its shares took

NASDAQ:VYGRNYSE:NVSNASDAQ:NTLA

January 8, 2024 7:00 AM ET

Chipotle stock price can set a new all-time high in 2024

Thomas Hughes

Chipotle Mexican Grill analysts are raising their targets and see this stock trading at a new all-time high in 2024; digital and store count growth are why.

NYSE:CMG

January 8, 2024 6:59 AM ET

Spirit AeroSystems stock will rally on Boeing's new orders

Gabriel Osorio-Mazilli

Boeing and Airbus are back online, but new orders need to be sent to this stock first, impacts to be reflected on February for a big earnings surprise

OTCMKTS:EADSYNYSE:MSNYSE:GS

January 8, 2024 6:45 AM ET

Apple stock at a crossroads, is now the time to buy?

Ryan Hasson

Apple's stock has dropped by almost 6% since the start of the year and faced four consecutive days of selling pressure, approaching its 200-day SMA.

NASDAQ:AAPL

January 8, 2024 6:45 AM ET

Bank of America and Citigroup are banking stocks that could soar

Gabriel Osorio-Mazilli

The new super cycle in the market is about to begin, and some analysts are already pouring all over certain banking stocks, here's why these two are top picks

NYSE:BACNYSE:CNYSE:BCS

January 8, 2024 6:26 AM ET

Peloton Stock surges on TikTok deal...can it keep up the pace?

MarketBeat Staff

Buzz around Peloton stock has picked up in recent weeks as the market’s risk appetite has increased - and as Peloton’s news flow has been rather bullish.

NASDAQ:PTONNASDAQ:METANASDAQ:LULU

January 8, 2024 6:26 AM ET

2 low-priced gene therapy stocks to speculate on

Jea Yu

Gene therapy differs from gene editing, which is getting the lion's share of headlines. While gene editing is a form of gene therapy, there are basic diffe

NASDAQ:BLUENASDAQ:SGMONASDAQ:VRTX

January 8, 2024 6:16 AM ET

There's a new buy signal flashing for these stocks, Dalio effect?

Gabriel Osorio-Mazilli

Chinese stocks, particularly Alibaba and JD.com, could see triple-digit rallies soon, or so do these indicators suggest. Barron's is boldly agreeing

NASDAQ:MCHINASDAQ:PDDNYSE:BABA

January 8, 2024 5:35 AM ET

Rate cuts could send MasTec stock earnings through the roof

Gabriel Osorio-Mazilli

The new economy is going to create a boost of activity in this sector, and MasTec earnings are set to soar by that same reason, analysts projections agree

NYSE:PHMNYSE:DHINYSE:GS

Page 52 of 68

« Most Recent ‹ More Recent 49 50 51 52 53 54 55 Earlier › Earliest »

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Don Miller, Senior Content Manager at MarketBeat

Articles Reviewed by Don Miller - Page 52

Will Danaher stock hit new highs in 2024?

3 health care stocks off to strong starts in 2024

Nike navigates a new course without Tiger

Apple just flashed the mother of all buy signals

Acuity Brands stock: A good play on falling rates

Five Below falls below EMA; is it time to buy the dip?

Where will S&P 500 go after new bullish levels?

3 bullish mid-cap earnings plays for January 2024

4 hot midcaps that the insiders are buying

Mobileye gets poked on weak forecasts, buying opportunity

Chevron stock made it to Barron's top 2024 picks

Johnson & Johnson: Biotech a shot in the arm for future growth?

Boeing Takes a hit after 737 Max grounding

Boeing stock gaps down 8.50% on new round of 737 Max woes

Merck, the Dow's hottest stock, gets set to report Q4 financials

Voyager Therapeutics stock pops 30% on deal with Novartis

Chipotle stock price can set a new all-time high in 2024

Spirit AeroSystems stock will rally on Boeing's new orders

Apple stock at a crossroads, is now the time to buy?

Bank of America and Citigroup are banking stocks that could soar

Peloton Stock surges on TikTok deal...can it keep up the pace?

2 low-priced gene therapy stocks to speculate on

There's a new buy signal flashing for these stocks, Dalio effect?

Rate cuts could send MasTec stock earnings through the roof

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Don Miller, Senior Content Manager at MarketBeat

Articles Reviewed by Don Miller - Page 52

Will Danaher stock hit new highs in 2024?

3 health care stocks off to strong starts in 2024

Nike navigates a new course without Tiger

Apple just flashed the mother of all buy signals

Acuity Brands stock: A good play on falling rates

Five Below falls below EMA; is it time to buy the dip?

Where will S&P 500 go after new bullish levels?

3 bullish mid-cap earnings plays for January 2024

4 hot midcaps that the insiders are buying

Mobileye gets poked on weak forecasts, buying opportunity

Chevron stock made it to Barron's top 2024 picks

Johnson & Johnson: Biotech a shot in the arm for future growth?

Boeing Takes a hit after 737 Max grounding

Boeing stock gaps down 8.50% on new round of 737 Max woes

Merck, the Dow's hottest stock, gets set to report Q4 financials

Voyager Therapeutics stock pops 30% on deal with Novartis

Chipotle stock price can set a new all-time high in 2024

Spirit AeroSystems stock will rally on Boeing's new orders

Apple stock at a crossroads, is now the time to buy?

Bank of America and Citigroup are banking stocks that could soar

Peloton Stock surges on TikTok deal...can it keep up the pace?

2 low-priced gene therapy stocks to speculate on

There's a new buy signal flashing for these stocks, Dalio effect?

Rate cuts could send MasTec stock earnings through the roof

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools